Tag: disability

Life Backup Plan App by Galacxia, Inc. Recognized for Great Potential in Pepperdine’s Most Fundable Companies Competition

Aliso Viejo, CA , June 18, 2025 (GLOBE NEWSWIRE) -- Galacxia, Inc., developer of the Life Backup Plan digital health platform, proudly announces its advancement to the second round of Pepperdine University’s Most Fundable Companies® 2025 competition. The company earned a “B” rating, reflecting “Great Potential” among a competitive national pool of startups evaluated for scalability, business fundamentals, and investor appeal.

Rewind Therapeutics Strengthens Scientific Advisory Board with Leading International Neurology Experts as it Advances First-in-Class Remyelination Therapy

Professors Shiv Saidha, Cristina Granziera, David Leppert, and Roberto Furlan are world-renowned experts in neuroimaging, multiple sclerosis (MS) biomarkers, neuroimmunology, and translational drug developmentAppointments...

Introducing the TELUS Mental Health Index: Nearly half of employees in South Korea experiencing feelings of depression and anxiety, impacting workplace productivity

More than one in three workers in South Korea have no emergency savings; women's mental health lags and more than two in five feel...

Newsweek Names Kroger One of America’s Most Trustworthy Companies

Retailer recognized for outstanding associate, customer and investor trust scores CINCINNATI, June 16, 2025 /PRNewswire/ -- The Kroger Co. (NYSE: KR), America's grocer, today announced...

AARP Services Announces New AARP Member Benefits Launching This Summer

WASHINGTON, June 16, 2025 /PRNewswire/ -- Today, it has been announced that AARP members have the opportunity to take advantage of new benefits including from...

Connecticut Passes Law to Establish $2 Million Center of Excellence to Provide Veterans with Access to FDA-Approved Vivistim Therapy for Stroke Recovery

AUSTIN, Texas, June 16, 2025 /PRNewswire/ -- MicroTransponder®, Inc., a commercial-stage medical technology company and developer of the breakthrough Vivistim® PairedVNS™ System for chronic stroke...

Access Ready Strategic Joins the Consortium for Constituents with Disabilities (CCD) and Other Organizations on Vital Policy and Public Interest Positions

Many Groups and Organizations respond on Policy Issues WASHINGTON, June 12, 2025 /PRNewswire/ -- The recent rapid approach to policy changes at the Federal and...

Levicept to Present Further Analysis from Phase II Trial of Novel Neurotrophin-3 Inhibitor, LEVI-04, at EULAR

SANDWICH, United Kingdom, June 12, 2025 (GLOBE NEWSWIRE) -- Levicept Ltd, a biotechnology company focused on the development of LEVI-04, a first-in-class treatment for osteoarthritis, is to present new data from its large-scale Phase II trial of LEVI-04 at EULAR, the European Congress of Rheumatology in Barcelona, Spain.

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsDisability

In HelloNation, Auto Industry Experts David Mantz and David Mantz Jr. Examine Choosing the Right Mechanic in Southington, Connecticut

POST HOUSE REPORTS 88% YEAR-OVER-YEAR REVENUE GROWTH AS DEMAND FOR LUXURY WELLNESS EXPERIENCES ACCELERATES IN THE HAMPTONS

Canadian Investment Regulatory Organization Trading Halt – TVK

Tag: disability

Life Backup Plan App by Galacxia, Inc. Recognized for Great Potential in Pepperdine’s Most Fundable Companies Competition

Rewind Therapeutics Strengthens Scientific Advisory Board with Leading International Neurology Experts as it Advances First-in-Class Remyelination Therapy

Introducing the TELUS Mental Health Index: Nearly half of employees in South Korea experiencing feelings of depression and anxiety, impacting workplace productivity

Newsweek Names Kroger One of America’s Most Trustworthy Companies

AARP Services Announces New AARP Member Benefits Launching This Summer

Connecticut Passes Law to Establish $2 Million Center of Excellence to Provide Veterans with Access to FDA-Approved Vivistim Therapy for Stroke Recovery

Access Ready Strategic Joins the Consortium for Constituents with Disabilities (CCD) and Other Organizations on Vital Policy and Public Interest Positions

Levicept to Present Further Analysis from Phase II Trial of Novel Neurotrophin-3 Inhibitor, LEVI-04, at EULAR

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us